Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects

Anne J Wanders, Ingeborg A Brouwer, Els Siebelink, Martijn B Katan, Anne J Wanders, Ingeborg A Brouwer, Els Siebelink, Martijn B Katan

Abstract

Background: Trans fatty acids are produced either by industrial hydrogenation or by biohydrogenation in the rumens of cows and sheep. Industrial trans fatty acids lower high-density lipoprotein (HDL) cholesterol, raise low-density lipoprotein (LDL) cholesterol, and increase the risk of coronary heart disease. The effects of trans fatty acids from ruminants are less clear. We investigated the effect on blood lipids of cis-9, trans-11 conjugated linoleic acid (CLA), a trans fatty acid largely restricted to ruminant fats.

Methodology/principal findings: Sixty-one healthy women and men were sequentially fed each of three diets for three weeks, in random order, for a total of nine weeks. Diets were identical except for 7% of energy (approximately 20 g/day), which was provided either by oleic acid, by industrial trans fatty acids, or by a mixture of 80% cis-9, trans-11 and 20% trans-10, cis-12 CLA. After the oleic acid diet, mean (+/- SD) serum LDL cholesterol was 2.68+/-0.62 mmol/L compared to 3.00+/-0.66 mmol/L after industrial trans fatty acids (p<0.001), and 2.92+/-0.70 mmol/L after CLA (p<0.001). Compared to oleic acid, HDL-cholesterol was 0.05+/-0.12 mmol/L lower after industrial trans fatty acids (p = 0.001) and 0.06+/-0.10 mmol/L lower after CLA (p<0.001). The total-to-HDL cholesterol ratio was 11.6% higher after industrial trans fatty acids (p<0.001) and 10.0% higher after CLA (p<0.001) relative to the oleic acid diet.

Conclusions/significance: High intakes of an 80:20 mixture of cis-9, trans-11 and trans-10, cis-12 CLA raise the total to HDL cholesterol ratio in healthy volunteers. The effect of CLA may be somewhat less than that of industrial trans fatty acids.

Trial registration: ClinicalTrials.gov NCT00529828.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Flow chart of a randomized…
Figure 1. Flow chart of a randomized cross-over trial of the effect of Conjugated Linoleic Acid (CLA) on lipoprotein levels in 61 healthy subjects.
Each intervention period lasted 3 weeks; O, Oleic acid diet; I, Industrial trans fat diet; C, CLA diet. * 2 subjects dropped out early in the study, one for personal reasons and one because of illness, both unrelated to the trial. These subjects were not included in the analysis.

References

    1. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, et al. Trans-fatty acids intake and risk of myocardial infarction. Circulation. 1994;89:94–101.
    1. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341:581–585.
    1. Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol. 1997;145:876–887.
    1. Oomen CM, Ocke MC, Feskens EJ, van Erp-Baart MA, Kok FJ, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 2001;357:746–751.
    1. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601–1613.
    1. Turpeinen AM, Mutanen M, Aro A, Salminen I, Basu S, et al. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr. 2002;76:504–510.
    1. Mitchell PL, McLeod RS. Conjugated linoleic acid and atherosclerosis: Studies in animal models. Biochemistry and Cell Biology. 2008;86:293–301.
    1. Arbones-Mainar JM, Navarro MA, Guzman MA, Arnal C, Surra JC, et al. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis. 2006;189:318–327.
    1. LeDoux M, Laloux L, Fontaine JJ, Carpentier YA, Chardigny JM, et al. Rumenic acid significantly reduces plasma levels of LDL and small dense LDL cholesterol in hamsters fed a cholesterol- and lipid-enriched semi-purified diet. Lipids. 2007;42:135–141.
    1. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem. 2006;17:789–810.
    1. Salas-Salvado J, Marquez-Sandoval F, Bullo M. Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr. 2006;46:479–488.
    1. Desroches S, Chouinard PY, Galibois I, Corneau L, Delisle J, et al. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr. 2005;82:309–319.
    1. Tricon S, Burdge GC, Jones EL, Russell JJ, El-Khazen S, et al. Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am J Clin Nutr. 2006;83:744–753.
    1. Lock AL, Bauman DE. Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids. 2004;39:1197–1206.
    1. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990;323:439–445.
    1. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146–1155.
    1. de Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol. 2001;21:1233–1237.
    1. Hiemstra GK, de Roos NM, De Vries JHM, Leibbrandt A, Rasmussen E, et al. Anamnesemethode: snel en doelmatig? (Method of anamnesis: quick and efficient?). Ned Tijdschr Dieti. 2005;60:88–96.
    1. Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annual Review of Nutrition. 1997;17:305–324.
    1. Wanders AJ, Leder L, Banga JD, Katan MB, Brouwer IA. A high intake of conjugated linoleic acid does not affect liver and kidney function tests in healthy human subjects. Food and Chemical Toxicology. In press 2009
    1. Mitchikpe ECS, Dossa RAM, Ategbo EAD, van Raaij JMA, Hulshof PJM, et al. The supply of bioavailable iron and zinc may be affected by phytate in Beninese children. Journal of Food Composition and Analysis. 2008;21:17–25.
    1. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.
    1. Metcalfe LD, Schmitz AA, Pelka JR. Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis. Analytical Chemistry. 1966;38:514–515.
    1. Glatz JF, Soffers AE, Katan MB. Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man. Am J Clin Nutr. 1989;49:269–276.
    1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
    1. Wolfinger R. Covariance structure selection in general mixed models. Commun, Statist-Simula. 1993;22:1079–1106.
    1. Chardigny JM, Destaillats F, Malpuech-Brugere C, Moulin J, Bauman DE, et al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr. 2008;87:558–566.
    1. Naumann E, Carpentier YA, Saebo A, Lassel TS, Chardigny JM, et al. Cis-9, trans- 11 and trans-10, cis-12 conjugated linoleic acid (CLA) do not affect the plasma lipoprotein profile in moderately overweight subjects with LDL phenotype B. Atherosclerosis. 2006;188:167–174.
    1. Noone EJ, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr. 2002;88:243–251.
    1. Brussaard JH, Katan MB, Groot PHE. Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months. A comparison of two cholesterol diets. Atherosclerosis. 1982;42:205–219.
    1. Mensink RP, Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet. 1987;1:122–124.
    1. Tricon S, Burdge GC, Kew S, Banerjee T, Russell JJ, et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr. 2004;80:614–620.
    1. Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004;80:887–895.
    1. Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord. 2001;25:1129–1135.
    1. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans–metabolic effects. Lipids. 2001;36:773–781.
    1. Benito P, Nelson GJ, Kelley DS, Bartolini G, Schmidt PC, et al. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids. 2001;36:229–236.
    1. Berven G, Bye A, Hals O, Blankson H, Fagertun H, et al. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Techol. 2000;102:455–462.
    1. Lambert EV, Goedecke JH, Bluett K, Heggie K, Claassen A, et al. Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. Br J Nutr. 2007;97:1001–1011.
    1. Gaullier JM, Halse J, Hoivik HO, Hoye K, Syvertsen C, et al. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. Br J Nutr. 2007;97:550–560.
    1. Iwata T, Kamegai T, Yamauchi-Sato Y, Ogawa A, Kasai M, et al. Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers. J Oleo Sci. 2007;56:517–525.
    1. Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, et al. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. J Nutr. 2007;137:1188–1193.
    1. Weggemans RM, Zock PL, Urgert R, Katan MB. Differences between men and women in the response of serum cholesterol to dietary changes. European Journal of Clinical Investigation. 1999;29:827–834.
    1. Fritsche J, Steinhart H. Amounts of Conjugated Linoleic Acid (CLA) in German foods and evaluation of daily intake. Zeitschrift fur Lebensmittel -Untersuchung und -Forschung. 1998;206:77–82.
    1. Laloux L, Du Chaffaut L, Razanamahefa L, Lafay L. Trans fatty acid content of foods and intake levels in France. European Journal of Lipid Science and Technology. 2007;109:918–929.
    1. Elgersma A, Tamminga S, Ellen G. Modifying milk composition through forage. Animal Feed Science and Technology. 2006;131:207–225.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel